Cat cancer genomics sharpens One Health research focus

Researchers are making a stronger case for cats as meaningful partners in comparative oncology. A large 2026 Science study mapped the “oncogenome” of the domestic cat using 493 paired tumor-normal samples across 13 feline cancer types, finding multiple cancer-driving mutations that overlap with human disease, including frequent FBXW7 and PIK3CA alterations in feline mammary carcinoma. Separately, work on domestic cat hepadnavirus, a feline virus with similarities to human hepatitis B virus, has added evidence that viral DNA can integrate near cancer-related genes in feline hepatocellular carcinoma, reinforcing the idea that naturally occurring cancers in cats may help answer questions relevant to both veterinary and human medicine. (sciencedaily.com)

Why it matters: For veterinary professionals, the shift here is from cats being occasional analogs to being better-defined translational models. The new feline cancer genomics resource could support more precise diagnostics, biomarker development, and future treatment stratification, especially in aggressive mammary tumors. It also gives researchers a stronger framework for One Health and One Medicine studies, where findings from feline patients may inform human oncology, and vice versa, without losing sight of direct clinical benefit for cats themselves. (sanger.ac.uk)

What to watch: Watch for follow-on studies translating these genomic findings into feline clinical trials, drug-response validation, and expanded work on domestic cat hepadnavirus as a model for virus-associated liver cancer. (sciencedaily.com)